Ohr Pharmaceutical Inc. | Key People and Executives
Michael Ferguson
Chairman
Jason Scott Slakter
President, Chief Executive Officer & Director
June Sherie Almenoff
Independent Director
Thomas M. Riedhammer
Independent Director
Orin Zvi Hirschman
Independent Director
Michael A. Ferguson
Chairman
Jason Scott Slakter
President, Chief Executive Officer & Director
Samuel I. Backenroth
CFO & Principal Accounting Officer
Glenn L. Stoller
Chief Scientific Officer
Peter K. Kaiser
Senior Vice President-Product Development
Marlene Modi
Vice President-Preclinical & Regulatory Affairs
June Sherie Almenoff
Independent Director
Thomas M. Riedhammer
Independent Director
Orin Zvi Hirschman
Independent Director
Address |
800 Third Avenue New York New York 10022 United States
|
Employees
|
- |
Website |
http://www.ohrpharmaceutical.com |
Updated |
07/08/2019 |
Ohr Pharmaceutical, Inc. is a clinical stage company which develops novel therapies for ophthalmic diseases. Its product provides a non-invasive therapy to improve vision outcomes. The company was founded by Irach B. |